Graft versus Host Disease in the Bone Marrow, Liver and Thymus Humanized Mouse Model

Mice bearing a "humanized" immune system are valuable tools to experimentally manipulate human cells in vivo and facilitate disease models not normally possible in laboratory animals. Here we describe a form of GVHD that develops in NOD/SCID mice reconstituted with human fetal bone marrow,...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 7; no. 9; p. e44664
Main Authors Greenblatt, Matthew B., Vbranac, Vladimir, Tivey, Trevor, Tsang, Kelly, Tager, Andrew M., Aliprantis, Antonios O.
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 05.09.2012
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Mice bearing a "humanized" immune system are valuable tools to experimentally manipulate human cells in vivo and facilitate disease models not normally possible in laboratory animals. Here we describe a form of GVHD that develops in NOD/SCID mice reconstituted with human fetal bone marrow, liver and thymus (NS BLT mice). The skin, lungs, gastrointestinal tract and parotid glands are affected with progressive inflammation and sclerosis. Although all mice showed involvement of at least one organ site, the incidence of overt clinical disease was approximately 35% by 22 weeks after reconstitution. The use of hosts lacking the IL2 common gamma chain (NOD/SCID/γc(-/-)) delayed the onset of disease, but ultimately did not affect incidence. Genetic analysis revealed that particular donor HLA class I alleles influenced the risk for the development of GVHD. At a cellular level, GVHD is associated with the infiltration of human CD4+ T cells into the skin and a shift towards Th1 cytokine production. GVHD also induced a mixed M1/M2 polarization phenotype in a dermal murine CD11b+, MHC class II+ macrophage population. The presence of xenogenic GVHD in BLT mice both presents a major obstacle in the use of humanized mice and an opportunity to conduct preclinical studies on GVHD in a humanized model.
AbstractList Mice bearing a "humanized" immune system are valuable tools to experimentally manipulate human cells in vivo and facilitate disease models not normally possible in laboratory animals. Here we describe a form of GVHD that develops in NOD/SCID mice reconstituted with human fetal bone marrow, liver and thymus (NS BLT mice). The skin, lungs, gastrointestinal tract and parotid glands are affected with progressive inflammation and sclerosis. Although all mice showed involvement of at least one organ site, the incidence of overt clinical disease was approximately 35% by 22 weeks after reconstitution. The use of hosts lacking the IL2 common gamma chain (NOD/SCID/[gamma]c.sup.-/-) delayed the onset of disease, but ultimately did not affect incidence. Genetic analysis revealed that particular donor HLA class I alleles influenced the risk for the development of GVHD. At a cellular level, GVHD is associated with the infiltration of human CD4+ T cells into the skin and a shift towards Th1 cytokine production. GVHD also induced a mixed M1/M2 polarization phenotype in a dermal murine CD11b+, MHC class II+ macrophage population. The presence of xenogenic GVHD in BLT mice both presents a major obstacle in the use of humanized mice and an opportunity to conduct preclinical studies on GVHD in a humanized model.
Mice bearing a “humanized” immune system are valuable tools to experimentally manipulate human cells in vivo and facilitate disease models not normally possible in laboratory animals. Here we describe a form of GVHD that develops in NOD/SCID mice reconstituted with human fetal bone marrow, liver and thymus (NS BLT mice). The skin, lungs, gastrointestinal tract and parotid glands are affected with progressive inflammation and sclerosis. Although all mice showed involvement of at least one organ site, the incidence of overt clinical disease was approximately 35% by 22 weeks after reconstitution. The use of hosts lacking the IL2 common gamma chain (NOD/SCID/γc−/−) delayed the onset of disease, but ultimately did not affect incidence. Genetic analysis revealed that particular donor HLA class I alleles influenced the risk for the development of GVHD. At a cellular level, GVHD is associated with the infiltration of human CD4+ T cells into the skin and a shift towards Th1 cytokine production. GVHD also induced a mixed M1/M2 polarization phenotype in a dermal murine CD11b+, MHC class II+ macrophage population. The presence of xenogenic GVHD in BLT mice both presents a major obstacle in the use of humanized mice and an opportunity to conduct preclinical studies on GVHD in a humanized model.
Mice bearing a “humanized” immune system are valuable tools to experimentally manipulate human cells in vivo and facilitate disease models not normally possible in laboratory animals. Here we describe a form of GVHD that develops in NOD/SCID mice reconstituted with human fetal bone marrow, liver and thymus (NS BLT mice). The skin, lungs, gastrointestinal tract and parotid glands are affected with progressive inflammation and sclerosis. Although all mice showed involvement of at least one organ site, the incidence of overt clinical disease was approximately 35% by 22 weeks after reconstitution. The use of hosts lacking the IL2 common gamma chain (NOD/SCID/γc −/− ) delayed the onset of disease, but ultimately did not affect incidence. Genetic analysis revealed that particular donor HLA class I alleles influenced the risk for the development of GVHD. At a cellular level, GVHD is associated with the infiltration of human CD4+ T cells into the skin and a shift towards Th1 cytokine production. GVHD also induced a mixed M1/M2 polarization phenotype in a dermal murine CD11b+, MHC class II+ macrophage population. The presence of xenogenic GVHD in BLT mice both presents a major obstacle in the use of humanized mice and an opportunity to conduct preclinical studies on GVHD in a humanized model.
Mice bearing a "humanized" immune system are valuable tools to experimentally manipulate human cells in vivo and facilitate disease models not normally possible in laboratory animals. Here we describe a form of GVHD that develops in NOD/SCID mice reconstituted with human fetal bone marrow, liver and thymus (NS BLT mice). The skin, lungs, gastrointestinal tract and parotid glands are affected with progressive inflammation and sclerosis. Although all mice showed involvement of at least one organ site, the incidence of overt clinical disease was approximately 35% by 22 weeks after reconstitution. The use of hosts lacking the IL2 common gamma chain (NOD/SCID/γc(-/-)) delayed the onset of disease, but ultimately did not affect incidence. Genetic analysis revealed that particular donor HLA class I alleles influenced the risk for the development of GVHD. At a cellular level, GVHD is associated with the infiltration of human CD4+ T cells into the skin and a shift towards Th1 cytokine production. GVHD also induced a mixed M1/M2 polarization phenotype in a dermal murine CD11b+, MHC class II+ macrophage population. The presence of xenogenic GVHD in BLT mice both presents a major obstacle in the use of humanized mice and an opportunity to conduct preclinical studies on GVHD in a humanized model.
Mice bearing a "humanized" immune system are valuable tools to experimentally manipulate human cells in vivo and facilitate disease models not normally possible in laboratory animals. Here we describe a form of GVHD that develops in NOD/SCID mice reconstituted with human fetal bone marrow, liver and thymus (NS BLT mice). The skin, lungs, gastrointestinal tract and parotid glands are affected with progressive inflammation and sclerosis. Although all mice showed involvement of at least one organ site, the incidence of overt clinical disease was approximately 35% by 22 weeks after reconstitution. The use of hosts lacking the IL2 common gamma chain (NOD/SCID/γc(-/-)) delayed the onset of disease, but ultimately did not affect incidence. Genetic analysis revealed that particular donor HLA class I alleles influenced the risk for the development of GVHD. At a cellular level, GVHD is associated with the infiltration of human CD4+ T cells into the skin and a shift towards Th1 cytokine production. GVHD also induced a mixed M1/M2 polarization phenotype in a dermal murine CD11b+, MHC class II+ macrophage population. The presence of xenogenic GVHD in BLT mice both presents a major obstacle in the use of humanized mice and an opportunity to conduct preclinical studies on GVHD in a humanized model.Mice bearing a "humanized" immune system are valuable tools to experimentally manipulate human cells in vivo and facilitate disease models not normally possible in laboratory animals. Here we describe a form of GVHD that develops in NOD/SCID mice reconstituted with human fetal bone marrow, liver and thymus (NS BLT mice). The skin, lungs, gastrointestinal tract and parotid glands are affected with progressive inflammation and sclerosis. Although all mice showed involvement of at least one organ site, the incidence of overt clinical disease was approximately 35% by 22 weeks after reconstitution. The use of hosts lacking the IL2 common gamma chain (NOD/SCID/γc(-/-)) delayed the onset of disease, but ultimately did not affect incidence. Genetic analysis revealed that particular donor HLA class I alleles influenced the risk for the development of GVHD. At a cellular level, GVHD is associated with the infiltration of human CD4+ T cells into the skin and a shift towards Th1 cytokine production. GVHD also induced a mixed M1/M2 polarization phenotype in a dermal murine CD11b+, MHC class II+ macrophage population. The presence of xenogenic GVHD in BLT mice both presents a major obstacle in the use of humanized mice and an opportunity to conduct preclinical studies on GVHD in a humanized model.
Mice bearing a “humanized” immune system are valuable tools to experimentally manipulate human cells in vivo and facilitate disease models not normally possible in laboratory animals. Here we describe a form of GVHD that develops in NOD/SCID mice reconstituted with human fetal bone marrow, liver and thymus (NS BLT mice). The skin, lungs, gastrointestinal tract and parotid glands are affected with progressive inflammation and sclerosis. Although all mice showed involvement of at least one organ site, the incidence of overt clinical disease was approximately 35% by 22 weeks after reconstitution. The use of hosts lacking the IL2 common gamma chain (NOD/SCID/γc −/− ) delayed the onset of disease, but ultimately did not affect incidence. Genetic analysis revealed that particular donor HLA class I alleles influenced the risk for the development of GVHD. At a cellular level, GVHD is associated with the infiltration of human CD4+ T cells into the skin and a shift towards Th1 cytokine production. GVHD also induced a mixed M1/M2 polarization phenotype in a dermal murine CD11b+, MHC class II+ macrophage population. The presence of xenogenic GVHD in BLT mice both presents a major obstacle in the use of humanized mice and an opportunity to conduct preclinical studies on GVHD in a humanized model.
Mice bearing a "humanized" immune system are valuable tools to experimentally manipulate human cells in vivo and facilitate disease models not normally possible in laboratory animals. Here we describe a form of GVHD that develops in NOD/SCID mice reconstituted with human fetal bone marrow, liver and thymus (NS BLT mice). The skin, lungs, gastrointestinal tract and parotid glands are affected with progressive inflammation and sclerosis. Although all mice showed involvement of at least one organ site, the incidence of overt clinical disease was approximately 35% by 22 weeks after reconstitution. The use of hosts lacking the IL2 common gamma chain (NOD/SCID/ gamma c-/-) delayed the onset of disease, but ultimately did not affect incidence. Genetic analysis revealed that particular donor HLA class delta alleles influenced the risk for the development of GVHD. At a cellular level, GVHD is associated with the infiltration of human CD4+ T cells into the skin and a shift towards Th1 cytokine production. GVHD also induced a mixed M1/M2 polarization phenotype in a dermal murine CD11b+, MHC class II+ macrophage population. The presence of xenogenic GVHD in BLT mice both presents a major obstacle in the use of humanized mice and an opportunity to conduct preclinical studies on GVHD in a humanized model.
Audience Academic
Author Vbranac, Vladimir
Aliprantis, Antonios O.
Tsang, Kelly
Greenblatt, Matthew B.
Tivey, Trevor
Tager, Andrew M.
AuthorAffiliation 4 Department of Medicine, Division of Rheumatology, Allergy and Immunology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
2 Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, United States of America
1 Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America
University of California, San Francisco, United States of America
3 Ragon Institute of Massachusetts General Hospital, Massachusetts Institutes of Technology, and Harvard and Division of AIDS, Harvard Medical School, Charlestown, Massachusetts, United States of America
AuthorAffiliation_xml – name: 1 Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America
– name: 3 Ragon Institute of Massachusetts General Hospital, Massachusetts Institutes of Technology, and Harvard and Division of AIDS, Harvard Medical School, Charlestown, Massachusetts, United States of America
– name: University of California, San Francisco, United States of America
– name: 2 Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, United States of America
– name: 4 Department of Medicine, Division of Rheumatology, Allergy and Immunology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
Author_xml – sequence: 1
  givenname: Matthew B.
  surname: Greenblatt
  fullname: Greenblatt, Matthew B.
– sequence: 2
  givenname: Vladimir
  surname: Vbranac
  fullname: Vbranac, Vladimir
– sequence: 3
  givenname: Trevor
  surname: Tivey
  fullname: Tivey, Trevor
– sequence: 4
  givenname: Kelly
  surname: Tsang
  fullname: Tsang, Kelly
– sequence: 5
  givenname: Andrew M.
  surname: Tager
  fullname: Tager, Andrew M.
– sequence: 6
  givenname: Antonios O.
  surname: Aliprantis
  fullname: Aliprantis, Antonios O.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22957096$$D View this record in MEDLINE/PubMed
BookMark eNqNk29v0zAQxiM0xLbCN0AQCQmBRIv_JU54gTQGbJVaTYLCW8txnNZVEhfbGYxPz5WmqJkmQInk5PJ7npzvfKfRUWtbHUWPMZpgyvHrte1cK-vJBsIThBhLU3YvOsE5JeOUIHp08HwcnXq_RiihWZo-iI4JyROO8vQkWlw4WYX4Wjvf-fjS-hC_N15Lr2PTxmGl43fgH8-lc_b7q3hmgIxlW8aL1U2zVXSNbM1PXcZz24FobktdP4zuV7L2-lG_jqIvHz8szi_Hs6uL6fnZbKx4jsO4SAncuEiYKqqCJlLxSmWFwhVBWYaYLjBPdVkopUsJCIc3VOSMEJphpSQdRU93vpvaetEXxAtMSZowRigGYrojSivXYuNMI92NsNKI3wHrlkK6YFStRcJKmtMky4oSMVRxyRGpGIeEipRDOuD1tv9bVzS6VLoNTtYD0-GX1qzE0l4LyijDPAeDF72Bs9867YNojFe6rmWroXgCE4IxQyxF_0YRdBJRzhJAn91C7y5ETy0l7NW0lYUU1dZUnCWMUig4LKNocgcFV6kbo-AgVAbiA8HLgQCYoH-Epey8F9PPn_6fvfo6ZJ8fsCst67Dytu6Csa0fgk8Om_KnG_sTDsCbHaCc9d7pSigT5NYHtmZqqKTYjtO-aGI7TqIfJxCzW-K9_19lvwB2ACHh
CitedBy_id crossref_primary_10_1172_JCI80562
crossref_primary_10_1371_journal_pone_0217345
crossref_primary_10_3389_fimmu_2018_00817
crossref_primary_10_3389_fonc_2020_604121
crossref_primary_10_1128_AAC_05036_14
crossref_primary_10_1530_ERC_18_0063
crossref_primary_10_1128_JVI_00814_19
crossref_primary_10_3390_cells10123497
crossref_primary_10_3390_cancers12061615
crossref_primary_10_3390_ijms23169195
crossref_primary_10_1007_s00335_019_09796_2
crossref_primary_10_1016_j_mbm_2023_100014
crossref_primary_10_1002_JLB_5AB0820_542RR
crossref_primary_10_1016_j_bbcan_2020_188458
crossref_primary_10_1038_s41571_022_00721_2
crossref_primary_10_3390_antibiotics13070640
crossref_primary_10_1084_jem_20201908
crossref_primary_10_3389_fimmu_2018_00649
crossref_primary_10_3389_fcimb_2020_00150
crossref_primary_10_2217_imt_2017_0028
crossref_primary_10_1002_ame2_12407
crossref_primary_10_1016_j_celrep_2017_08_003
crossref_primary_10_3389_fonc_2018_00559
crossref_primary_10_3389_fimmu_2023_1107848
crossref_primary_10_1002_cpz1_852
crossref_primary_10_3389_fimmu_2018_02734
crossref_primary_10_1016_j_trre_2014_02_002
crossref_primary_10_1080_19420862_2021_1993522
crossref_primary_10_3389_fonc_2021_784947
crossref_primary_10_1016_j_trecan_2018_03_009
crossref_primary_10_1097_QAD_0000000000001674
crossref_primary_10_1177_0300985820948822
crossref_primary_10_1093_infdis_jit319
crossref_primary_10_1016_j_coviro_2016_06_010
crossref_primary_10_1172_jci_insight_120430
crossref_primary_10_4049_immunohorizons_2300115
crossref_primary_10_1186_s12977_020_00515_3
crossref_primary_10_1016_j_jim_2014_06_010
crossref_primary_10_1038_nrmicro3309
crossref_primary_10_1038_s41684_023_01196_z
crossref_primary_10_3389_fimmu_2021_643852
crossref_primary_10_3390_pathogens12040608
crossref_primary_10_1007_s11427_019_1691_x
crossref_primary_10_1016_j_ajpath_2017_02_015
crossref_primary_10_3389_fimmu_2021_636775
crossref_primary_10_3390_v4123701
crossref_primary_10_3390_pathogens11060611
crossref_primary_10_1093_infdis_jit448
crossref_primary_10_3390_microorganisms11081984
crossref_primary_10_1016_j_virol_2014_05_036
crossref_primary_10_3389_fimmu_2021_663328
crossref_primary_10_3390_v15020478
crossref_primary_10_3389_fonc_2020_00212
crossref_primary_10_3389_fimmu_2020_619236
crossref_primary_10_1242_bio_013201
crossref_primary_10_1146_annurev_virology_101416_041703
crossref_primary_10_1016_j_jtocrr_2024_100781
crossref_primary_10_1371_journal_pone_0241375
crossref_primary_10_1016_j_jaut_2015_06_006
crossref_primary_10_1128_JVI_01394_21
crossref_primary_10_1186_s12977_017_0376_z
crossref_primary_10_1177_0300985820913265
crossref_primary_10_3390_v15020365
crossref_primary_10_1016_j_jaut_2021_102612
crossref_primary_10_1080_17460441_2022_2131765
crossref_primary_10_1177_0192623319886304
crossref_primary_10_1371_journal_pone_0088205
crossref_primary_10_1186_s13287_024_03756_7
crossref_primary_10_3389_fcimb_2022_920204
crossref_primary_10_1002_jcb_26002
crossref_primary_10_1002_JLB_5HI1018_410RR
crossref_primary_10_1371_journal_pone_0060680
crossref_primary_10_1016_j_bmc_2015_06_039
crossref_primary_10_1111_cei_12180
crossref_primary_10_3389_fimmu_2022_936164
crossref_primary_10_1017_erm_2023_4
crossref_primary_10_1371_journal_pone_0133216
crossref_primary_10_1089_aid_2022_0057
crossref_primary_10_1146_annurev_cancerbio_050520_100526
crossref_primary_10_1016_j_jim_2015_02_007
crossref_primary_10_1097_01_bcr_0000440705_91099_cc
crossref_primary_10_1016_j_trecan_2021_08_004
crossref_primary_10_1093_toxsci_kfz045
crossref_primary_10_1182_blood_2016_04_709584
crossref_primary_10_3390_vaccines4030030
crossref_primary_10_3389_fimmu_2020_617516
crossref_primary_10_1016_j_bbmt_2013_06_007
crossref_primary_10_1016_j_jim_2014_02_011
crossref_primary_10_1113_JP275325
crossref_primary_10_1172_JCI90745
crossref_primary_10_1007_s00262_021_02897_5
crossref_primary_10_1016_j_jim_2014_04_008
crossref_primary_10_1111_ajt_15763
crossref_primary_10_1016_j_jaci_2016_03_053
crossref_primary_10_1016_j_bcp_2019_113672
crossref_primary_10_1016_j_cr_2018_09_002
crossref_primary_10_3390_vaccines8010089
crossref_primary_10_1111_imr_12128
crossref_primary_10_1186_1742_4690_10_121
crossref_primary_10_1093_infdis_jiv538
crossref_primary_10_1016_j_ejphar_2015_03_022
crossref_primary_10_1016_j_jcpa_2014_12_010
crossref_primary_10_2967_jnumed_116_186007
crossref_primary_10_3390_vaccines9030198
crossref_primary_10_1182_blood_2013_06_506949
crossref_primary_10_1073_pnas_1705301114
crossref_primary_10_1177_0192623319844484
crossref_primary_10_1136_jitc_2023_008516
crossref_primary_10_3390_vaccines8010098
crossref_primary_10_1128_microbiolspec_BAI_0019_2019
crossref_primary_10_3389_fimmu_2019_00203
crossref_primary_10_1093_infdis_jiw637
crossref_primary_10_1002_ame2_12349
ContentType Journal Article
Copyright COPYRIGHT 2012 Public Library of Science
Greenblatt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2012 Greenblatt et al 2012 Greenblatt et al
Copyright_xml – notice: COPYRIGHT 2012 Public Library of Science
– notice: Greenblatt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2012 Greenblatt et al 2012 Greenblatt et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0044664
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agriculture Science Database
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Agricultural Science Database


MEDLINE
MEDLINE - Academic


AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Medicine
Biology
DocumentTitleAlternate GVHD in BLT Humanized Mice
EISSN 1932-6203
ExternalDocumentID 1326544231
oai_doaj_org_article_54d393588bd040f7a702f47c8bb67880
PMC3434179
2943644211
A543308854
22957096
10_1371_journal_pone_0044664
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States--US
Massachusetts
Germany
GeographicLocations_xml – name: United States--US
– name: Massachusetts
– name: Germany
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: P01 AI078897
– fundername: NIAMS NIH HHS
  grantid: K08AR054859
– fundername: NIAMS NIH HHS
  grantid: K08 AR054859
– fundername: NIDDK NIH HHS
  grantid: P30 DK043351
– fundername: NIAID NIH HHS
  grantid: P30AI060354
– fundername: NIAID NIH HHS
  grantid: P01AI078897
– fundername: NIGMS NIH HHS
  grantid: T32 GM007753
– fundername: NIAID NIH HHS
  grantid: P30 AI060354
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPNFZ
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PYCSY
RIG
RNS
RPM
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
PV9
RZL
BBORY
PMFND
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
AAPBV
ABPTK
N95
ID FETCH-LOGICAL-c791t-b62b621b54cbfb35ac7fc8bc1f208804eb176edbccedacbf776e0b9422381cca3
IEDL.DBID M48
ISSN 1932-6203
IngestDate Sun May 07 16:28:44 EDT 2023
Wed Aug 27 00:56:43 EDT 2025
Thu Aug 21 14:33:14 EDT 2025
Thu Jul 10 22:21:30 EDT 2025
Fri Jul 11 05:54:36 EDT 2025
Sat Aug 16 21:32:27 EDT 2025
Tue Jun 17 21:24:09 EDT 2025
Tue Jun 10 20:29:50 EDT 2025
Fri Jun 27 04:38:13 EDT 2025
Fri Jun 27 04:36:46 EDT 2025
Thu May 22 21:19:52 EDT 2025
Tue Aug 05 11:41:56 EDT 2025
Tue Jul 01 02:42:18 EDT 2025
Thu Apr 24 22:51:38 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c791t-b62b621b54cbfb35ac7fc8bc1f208804eb176edbccedacbf776e0b9422381cca3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Conceived and designed the experiments: MBG AOA AMT. Performed the experiments: MBG VV TT KT. Analyzed the data: MGB AOA TT. Contributed reagents/materials/analysis tools: MGB AOA AMT VV KT. Wrote the paper: MBG AOA AMT.
Competing Interests: The authors have declared that no competing interests exist.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0044664
PMID 22957096
PQID 1326544231
PQPubID 1436336
PageCount e44664
ParticipantIDs plos_journals_1326544231
doaj_primary_oai_doaj_org_article_54d393588bd040f7a702f47c8bb67880
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3434179
proquest_miscellaneous_1221140460
proquest_miscellaneous_1038603745
proquest_journals_1326544231
gale_infotracmisc_A543308854
gale_infotracacademiconefile_A543308854
gale_incontextgauss_ISR_A543308854
gale_incontextgauss_IOV_A543308854
gale_healthsolutions_A543308854
pubmed_primary_22957096
crossref_citationtrail_10_1371_journal_pone_0044664
crossref_primary_10_1371_journal_pone_0044664
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-09-05
PublicationDateYYYYMMDD 2012-09-05
PublicationDate_xml – month: 09
  year: 2012
  text: 2012-09-05
  day: 05
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2012
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References PLoS One. 2013;8(5). doi:10.1371/annotation/e413f2a1-5767-4c82-9e27-dd556155f124
References_xml – reference: - PLoS One. 2013;8(5). doi:10.1371/annotation/e413f2a1-5767-4c82-9e27-dd556155f124
SSID ssj0053866
Score 2.431803
Snippet Mice bearing a "humanized" immune system are valuable tools to experimentally manipulate human cells in vivo and facilitate disease models not normally...
Mice bearing a “humanized” immune system are valuable tools to experimentally manipulate human cells in vivo and facilitate disease models not normally...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e44664
SubjectTerms Acquired immune deficiency syndrome
AIDS
Allografts
Analysis
Animal models
Animals
B cells
Biology
Bone marrow
Bone Marrow - pathology
Bone marrow transplantation
CD11b antigen
CD4 antigen
CD4-Positive T-Lymphocytes - cytology
Cytokines - metabolism
Disease Models, Animal
Fetuses
Gastrointestinal tract
Genetic analysis
Glands
Graft versus host disease
Graft vs Host Disease - etiology
Graft vs Host Disease - immunology
Graft-versus-host reaction
Histocompatibility antigen HLA
Histocompatibility Antigens Class I - metabolism
Histocompatibility Antigens Class II - metabolism
HIV
Human immunodeficiency virus
Humans
Immune system
Incidence
Infiltration
Inflammation
Interleukin 2
Interleukin-2 - metabolism
Laboratory animals
Laboratory tests
Liver
Liver - pathology
Lungs
Lymphocytes
Lymphocytes T
Macrophages
Macrophages - metabolism
Major histocompatibility complex
Medicine
Mice
Mice, Inbred NOD
Mice, SCID
Phenotypes
Risk
Rodents
Scleroderma
Sclerosis
Skin
Skin - metabolism
Spleen - cytology
T cells
Thymus
Thymus Gland - pathology
Womens health
Xenografts
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LbxMxELZQTr0gyquBAi5CAiS2zfqZPRbUUjiABC3qzVo_tlRKN1E3OcCv74ztrLqoohyQckk83jjzdjz-hpBXuoY8wHtbNCyEQjBfFdZzC-Ze4YYDYr6PBbJf1NGJ-HwqT6-1-sKasAQPnBi3B0-KIF1T60HfGl3rCWuEdlNrwc9O424dYt56M5V8MFixUvmiHNflXpbL7mLeht10hikGgSji9fdeebSYzbubUs4_KyevhaLDe-RuziHpflr7JrkT2vtkM1tpR99kKOm3D8jxx8u6WVIsvVh1FC900HwiQ89bCrkftbBWehGRGN_RGRZp0Lr1MPTrAmdEeIzfwVP8hwAIsW_OQ3JyeHD84ajIfRQKp6tyWVjF4FVaKZxtLJe10w3wz5UNAx8zEeCutQreOhd8DSQa3k1sJRiGc5Awf0RGLaxmi9DSCyclVzIESKQcakAVhJo4xG5ishkTvmaqcRlkHHtdzEw8OdOw2Ug8MigKk0UxJkU_a5FANm6hf4_y6mkRIjt-AIpjsuKY2xRnTF6gtE26b9obutmXgnPgi4SveRkpECajxTqcs3rVdebT1x__QPT924DodSZq5sAOV-e7D_CbEH5rQLk9oARjd4PhLdTNNVc64BFTUkBOXMLMtb7ePLzTD-NDsbauDaA7BiHyFcIQyb_QMFYiEJMCtj1OJtBzHxvCa9gJj4keGMdAPMOR9vxnRDLngmMHvCf_Q55PyQYksyzW_8ltMlpersIzSBiX9nn0DVeWCWjB
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZguXBBlFe3FDAICZBIm4cdb06oBbYLoiDBFvVmxY-0lbbJdpM9wK9nxnECQVVB2kvW48SZ8Twcj78h5LnIIQ4wRgVFbG3AYpMFyiQK1D3DBQf4fOMSZD-nsyP28Zgf-w9utU-r7GyiM9Sm0viNfBdWTSln4PyjN8uLAKtG4e6qL6FxndyIwNNgStdketBZYtDlNPXH5RIR7Xrp7Cyr0u60O5ls4I4can9vm0fLRVVfFnj-nT_5h0Oa3ia3fCRJ91rRb5BrtrxDNryu1vSlB5R-dZfMD1Z50VBMwFjXdFbVDX3X7svQs5JCBEj3Yaz00OExvqafMFWD5qWh89Mf59jDgWT8tIYeVmvohPXTFvfI0fT9_O0s8NUUAi2yqAlUGsMvUpxpVaiE51oUeqJ0VMRgaUIGRluk1iitrcmBRMBVqDIWo1MHOSf3yaiE0WwSGhmmOU9Sbi2EUxrnQWZZGmpEcIp5MSZJx1SpPdQ4VrxYSLd_JmDJ0fJIoiikF8WYBH2vZQu18Q_6fZRXT4tA2e6PanUivd5JmIgO422iDJirQuQijAsm4MUVuOlJOCZPUNqyPXXaq7vc4yxJgC8cHvPMUSBYRonZOCf5uq7lhy_f_4Po29cB0QtPVFTADp37ExDwTgjCNaDcHlCCyutB8ybOzY4rtfytHNCzm6-XNz_tm_GmmGFXWpg7EoHyUwQj4lfQxHGEcEwpsO1BqwI997EsvID18JiIgXIMxDNsKc9OHZ55whKsg7d19dAfkpsQrMYuv49vk1GzWttHEBA26rHT-l-ZEF_5
  priority: 102
  providerName: ProQuest
Title Graft versus Host Disease in the Bone Marrow, Liver and Thymus Humanized Mouse Model
URI https://www.ncbi.nlm.nih.gov/pubmed/22957096
https://www.proquest.com/docview/1326544231
https://www.proquest.com/docview/1038603745
https://www.proquest.com/docview/1221140460
https://pubmed.ncbi.nlm.nih.gov/PMC3434179
https://doaj.org/article/54d393588bd040f7a702f47c8bb67880
http://dx.doi.org/10.1371/journal.pone.0044664
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELe27oUXxPhaYRSDkACJVIljx-0DQutoVxAdaLSob1HsONukkpSmlRgP_O3cOR8iqDCkylLrcz7O9-X6_DtCnskI4oA4Vk7CjHE4i_uOin0F6t7HBQf4_NgmyJ4G4xl_PxfzHVLVbC0ZmG9d2mE9qdlq0f3-7eoNKPxrW7VBetWg7jJLTbfYoeS7ZA98k8SaBhNe7yuAdtvdS4xanIC5fnmY7m9XaTgri-lfW-7WcpHl28LSP7Mrf3NXo1vkZhln0qNCMPbJjklvk_1Sk3P6ooSbfnmHTE9WUbKmmJ6xyek4y9f0bbFrQy9TCvEhHcCz0olFa3xFP2AiB43SmE4vrr7iCAuh8cPEdJJtYBBWV1vcJbPRcHo8dspaC46WfW_tqIDBx1OCa5UoX0RaJrqntJcwsEMuB5MuAxMrrU0cAYmEb67qc4YuH6TAv0daKTzNAaFezLUQfiCMgWBLo5T0DQ9cjfhOTCRt4ldMDXUJRI71MBah3V2TsCApeBTiVITlVLSJU49aFkAc19APcL5qWoTRtj9kq_Ow1MoQxNQiwPVUDMYskZF0WcIlvLgCJ95z2-QxznZYnEmtjUF4JLjvA18E3OappUAojRRzdc6jTZ6H7z5--Q-iz2cNouclUZIBO3RUno-Ad0KIrgblYYMSDIJudB-gbFZcyYFHLBAc4mYPRlbyur37Sd2NF8X8u9SA7IQIox8gVJH4Bw1jHoI1BcC2-4UK1NzHovESVsttIhvK0ZieZk96eWHRzn3uY5W8B9dOxUNyA6JZZhMAxSFprVcb8wgixrXqkF05l9D2jj1sRycdsjcYnn4669j_YDrWSGD7c_gL7DdvMg
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGeYAXxPhaYTCDQIBEtsax4_YBoY3RtawdEnRobyZ2nG1SSUrTCo0_ir-RO-cDgqbBy6S-tD4n9t357lyff0fIUxlBHBDH2kuYtR5ncc_TcaBhufdwwwE-P3YJsgfh4JC_PxJHK-RndRcG0yorm-gMdZwZ_I98C3ZNoeDg_P03s28eVo3C09WqhEahFvv27Dts2fLXw12Q7zPG-u8mbwdeWVXAM7LnLzwdMvj4WnCjEx2IyMjEdLXxEwYrrsPBeMnQxtoYG0dAIuFbR_c4Q-cG8w3guVfIVR6AJ8eb6f29yvKD7QjD8npeIP2tUhs2Z1lqN4uTU95wf65KQO0LWrNplp8X6P6dr_mHA-zfJDfKyJVuF6q2SlZseouslrYhpy9KAOuXt8lkbx4lC4oJH8ucDrJ8QXeLcyB6mlKIOOkOjJWOHf7jKzrC1BAapTGdnJx9xR4OlOOHjek4W0InrNc2vUMOL4XPd0krhdGsEerH3AgRhMJaCN8M6l3P8rBjEDGKiaRNgoqpypTQ5lhhY6rceZ2ELU7BI4WiUKUo2sSre80KaI9_0O-gvGpaBOZ2P2TzY1WucwWK7zDlujoG85jISHZYwiVMXENY0O20yQZKWxW3XGvzorYFKBTwRcBrnjgKBOdIMfvnOFrmuRp--PwfRJ8-Noiel0RJBuwwUXnjAuaEoF8NyvUGJZgY02heQ92suJKr34sRelb6en7z47oZH4oZfakF3VEIzB8i-JG4gIYxH-GfQmDbvWIJ1NzHMvQS9t9tIhuLoyGeZkt6euLw0wMeYN29-xcPfYNcG0zGIzUaHuw_INchUGYut1Csk9ZivrQPIRhd6EfOAlDy5bJNzi81xZ9_
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGkRAviHFbYTCDQIBE1sax4_YBoW2lrOwCGh3am4kv2SaVpDSt0Php_DrOyQ2CpsHLpL60Pk7s43NzffwdQp7KCOIAa7UXM-c8zmzf0zbQoO593HCAz7d5gux-uH3I3x-JoyXys7oLg2mVlU3MDbVNDf5H3oFdUyg4OH-_E5dpER8HwzfTbx5WkMKT1qqcRiEiO-7sO2zfstejAaz1M8aGb8db215ZYcAzsu_PPR0y-PhacKNjHYjIyNj0tPFjBtrX5WDIZOisNsbZCEgkfOvqPmfo6GDuATz3CrkqA9lDHett1eklYEfCsLyqF0i_U0rG-jRN3HpxisobrjCvGFD7hdZ0kmbnBb1_527-4QyHN8mNMoqlG4XYLZMll9wiy6WdyOiLEsz65W0yfjeL4jnF5I9FRrfTbE4HxZkQPU0oRJ90E8ZK93IsyFd0F9NEaJRYOj45-4o9coCOH87SvXQBnbB22-QOObwUPt8lrQRGs0Kob7kRIgiFcxDKGZTBvuNh1yB6FBNxmwQVU5UpYc6x2sZE5Wd3ErY7BY8ULoUql6JNvLrXtID5-Af9Jq5XTYsg3fkP6exYlTqvQAlyfLmetmAqYxnJLou5hIlrCBF63TZZw9VWxY3X2tSoDcGDAPgi4DVPcgoE6khQ5I-jRZap0YfP_0H06aBB9LwkilNgh4nK2xcwJwQAa1CuNijB3JhG8wrKZsWVTP1WTOhZyev5zY_rZnwoZvclDmRHIUh_iEBI4gIaxnyEggqBbfcKFai5jyXpJezF20Q2lKOxPM2W5PQkx1IPeIA1-O5fPPQ1cg2Mjdod7e88INchZmZ5mqFYJa35bOEeQlw6149yA0DJl8u2OL8AF1ujgA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Graft+versus+Host+Disease+in+the+Bone+Marrow%2C+Liver+and+Thymus+Humanized+Mouse+Model&rft.jtitle=PloS+one&rft.au=Tsang%2C+Kelly&rft.au=Aliprantis%2C+Antonios+O&rft.au=Tivey%2C+Trevor&rft.au=Tager%2C+Andrew+M&rft.date=2012-09-05&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=7&rft.issue=9&rft.spage=e44664&rft_id=info:doi/10.1371%2Fjournal.pone.0044664&rft.externalDBID=n%2Fa&rft.externalDocID=A543308854
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon